Beta-Hydroxybutyrate (BHB) is a marker of metabolic ketosis in brain. To study ketogenic treatment spectral editing was developed to invert the signals in the 3.2-4.6 ppm spectral region for detecting BHB and co-edited signals. Using this spectral editing technique we found markedly elevated BHB signal in the human brain shortly after oral administration of 1,3-butanediol monoester of beta-hydroxybutyrate as compared to the control scan without consumption of the ketone ester.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords